Magnesium in Ketamine Administration in Treatment-Resistant Depression
Relationship between depression and magnesium levels is reported. This observational study examined whether serum magnesium concentration change over time of ketamine treatment course, also whether association between magnesium concentrations and treatment response measured with Montgomery-Åsberg De...
Saved in:
Main Authors: | Natalia Górska (Author), Wiesław Jerzy Cubała (Author), Jakub Słupski (Author), Mariusz Stanisław Wiglusz (Author), Maria Gałuszko-Węgielnik (Author), Mateusz Kawka (Author), Agata Grzegorzewska (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression
by: Adam Włodarczyk, et al.
Published: (2021) -
Residual Depressive Symptoms in Treatment-Resistant Bipolar Depression Following Short-Term Ketamine Administration
by: Michał Pastuszak, et al.
Published: (2024) -
Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
by: Aleksander Kwaśny, et al.
Published: (2023) -
Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms
by: Adam Włodarczyk, et al.
Published: (2023) -
Safety of Repeated Administration of Parenteral Ketamine for Depression
by: David Feifel, et al.
Published: (2020)